Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College (State Key Laboratory of Bioactive Substance and Function of Natural Medicines & NHC Key Laboratory of Biosynthesis of Natural Products), Beijing 100050, China.
School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 102488, China.
J Agric Food Chem. 2022 Apr 6;70(13):4076-4085. doi: 10.1021/acs.jafc.2c01029. Epub 2022 Mar 24.
Quercetin 3---acetylgalactosamine (Q3GalNAc), a derivative of dietary hyperoside, had never been enzymatically synthesized due to the lack of well-identified -acetylgalactosamine-transferase (GalNAc-T). Herein, PhUGT, an identified flavonoid 3--galactosyltransferase from , was demonstrated to display quercetin GalNAc-T activity, transferring a -acetylgalactosamine (GalNAc) from UDP--acetylgalactosamine (UDP-GalNAc) to the 3-OH of quercetin to form Q3GalNAc with a low conversion of 11.7% at 40 °C for 2 h. Protein engineering was thus performed, and the resultant PhUGT variant F368T got an enhanced conversion of 75.5% toward UDP-GalNAc. The enzymatically synthesized Q3GalNAc exhibited a comparable antioxidant activity with other quercetin 3--glycosides. Further studies revealed that PhUGT was a donor promiscuous glycosyltransferase (GT), recognizing seven sugar donors. This finding overturned a previous notion that PhUGT exclusively recognized UDP-galactose (UDP-Gal). The reason why PhUGT was mistaken for a UDP-Gal-specific GT was demonstrated to be a shorter reaction time, in which many quercetin 3--glycosides, except hyperoside, could not be effectively synthesized. The fact that the microbial cell factory expressing PhUGT could yield an array of Q3Gs further confirmed the donor promiscuity of PhUGT. This study laid a foundation for the scale production of Q3GalNAc and provided a potent biocatalyst capable of glycodiversifying quercetin as well.
槲皮素 3---乙酰半乳糖胺(Q3GalNAc)是膳食圣草酚的衍生物,由于缺乏鉴定良好的乙酰半乳糖胺转移酶(GalNAc-T),从未通过酶法合成。在此,从 中鉴定出的黄酮类 3--半乳糖基转移酶 PhUGT,被证明具有槲皮素 GalNAc-T 活性,能够将 -乙酰半乳糖胺(GalNAc)从 UDP--乙酰半乳糖胺(UDP-GalNAc)转移到槲皮素的 3-OH 上,在 40°C 下反应 2 小时,转化率低至 11.7%,形成 Q3GalNAc。因此进行了蛋白质工程改造,所得 PhUGT 变体 F368T 对 UDP-GalNAc 的转化率提高到 75.5%。酶法合成的 Q3GalNAc 具有与其他槲皮素 3--糖苷相当的抗氧化活性。进一步的研究表明,PhUGT 是一种供体混杂的糖基转移酶(GT),可识别七种糖供体。这一发现推翻了之前的观点,即 PhUGT 仅识别 UDP-半乳糖(UDP-Gal)。PhUGT 被误认为是 UDP-Gal 特异性 GT 的原因被证明是较短的反应时间,在此期间,许多槲皮素 3--糖苷,除圣草酚外,无法有效合成。表达 PhUGT 的微生物细胞工厂能够产生一系列 Q3Gs,这一事实进一步证实了 PhUGT 的供体混杂性。该研究为 Q3GalNAc 的规模化生产奠定了基础,并提供了一种能够糖基化多样化槲皮素的有效生物催化剂。